Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-02-27 @ 1:09 AM
Study NCT ID:
NCT04896320
Status:
WITHDRAWN
Last Update Posted:
2023-06-22
First Post:
2021-05-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer.
Sponsor:
Providence Health & Services
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-10
First Submit QC Date:
None
Study First Post Date:
2021-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-19
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL